Development and Validation of a Reversed-Phase High-performance Liquid Chromatography Method for Determination of Desmopressin in Chitosan Nanoparticles

被引:0
作者
Taghizadeh, S. M. [1 ]
Mohamadnia, F. [1 ]
Adlnasab, L. [1 ]
机构
[1] Iran Polymer & Petrochem Inst, Polymer Sci Fac, Dept Novel Drug Delivery Syst, Tehran, Iran
关键词
Desmopressin; high-performance liquid chromatography; in vitro; method validation; nanoparticle; LC-MS; DELIVERY; INTRANASAL; PEPTIDES; DEPOSITION; ABSORPTION; SYSTEM; DDAVP;
D O I
暂无
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
A simple isocratic reversed-phase high performance liquid chromatographic method was developed for determination of released desmopressin from chitosan nanoparticles in the in vitro media. The chromatographic separation was achieved with acetonitrile/water (25: 75, v/v), in which water contained 0.1% v/v trifluoroacetic acid with pH=2.5 as mobile phase, a Chromolith (R) Performance RP-18e column (150x4.6 mm; 5 mu m) kept at 40 degrees and ultraviolet detection at 220 nm. The compound was eluted isocritically at a constant flow rate of 1.6 ml/min. The method was validated according to the International Conference on Harmonisation guidelines. The validation characteristics included accuracy, precision, linearity rang, selectivity, limit of detection, limit of quantitation and robustness. The calibration curve was linear (r>0.9999) over the concentration rang 0.5-100 mu g/ml. The limit of detection and limit of quantitation in the release media were 0.05 and 0.5 mu g/ml, respectively. The proposed method had an accuracy of and intra-and inter-day precision <4.2. Furthermore, to evaluate the performance of the proposed method, it was used in the analysis of desmopressin level in real samples containing chitosan nanoparticles in the in vitro media.
引用
收藏
页码:221 / U140
页数:6
相关论文
共 18 条
  • [1] [Anonymous], 1990, Drug Invest
  • [2] Transdermal delivery of desmopressin using a coated microneedle array patch system
    Cormier, M
    Johnson, B
    Ameri, M
    Nyam, K
    Libiran, L
    Zhang, DD
    Daddona, P
    [J]. JOURNAL OF CONTROLLED RELEASE, 2004, 97 (03) : 503 - 511
  • [3] NASAL ABSORPTION OF DESMOPRESSIN IN RATS AND SHEEP - EFFECT OF A BIOADHESIVE MICROSPHERE DELIVERY SYSTEM
    CRITCHLEY, H
    DAVIS, SS
    FARRAJ, NF
    ILLUM, L
    [J]. JOURNAL OF PHARMACY AND PHARMACOLOGY, 1994, 46 (08) : 651 - 656
  • [4] Desmopressin - In adults with nocturia
    Cvetkovic, RS
    Plosker, GL
    [J]. DRUGS, 2005, 65 (01) : 99 - 107
  • [5] Dudkiewicz-Wilczynska Jadwiga, 2002, Acta Pol Pharm, V59, P163
  • [6] LC-MS determination of desmopressin acetate in human skin samples
    Getie, M
    Neubert, RHH
    [J]. JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS, 2004, 35 (04) : 921 - 927
  • [7] EFFECT OF VISCOSITY ON PARTICLE-SIZE, DEPOSITION, AND CLEARANCE OF NASAL DELIVERY SYSTEMS CONTAINING DESMOPRESSIN
    HARRIS, AS
    SVENSSON, E
    WAGNER, ZG
    LETHAGEN, S
    NILSSON, IM
    [J]. JOURNAL OF PHARMACEUTICAL SCIENCES, 1988, 77 (05) : 405 - 408
  • [8] INTRANASAL ADMINISTRATION OF PEPTIDES - NASAL DEPOSITION, BIOLOGICAL RESPONSE, AND ABSORPTION OF DESMOPRESSIN
    HARRIS, AS
    NILSSON, IM
    WAGNER, ZG
    ALKNER, U
    [J]. JOURNAL OF PHARMACEUTICAL SCIENCES, 1986, 75 (11) : 1085 - 1088
  • [9] Use of capillary electrophoresis and high-performance liquid chromatography for monitoring of glycosylation of the peptides dalargin and desmopressin
    Jiskra, J
    Pacakova, V
    Ticha, M
    Stulik, K
    Barth, T
    [J]. JOURNAL OF CHROMATOGRAPHY A, 1997, 761 (1-2) : 285 - 296
  • [10] PRODRUGS OF PEPTIDES .18. SYNTHESIS AND EVALUATION OF VARIOUS ESTERS OF DESMOPRESSIN (DDAVP)
    KAHNS, AH
    BUUR, A
    BUNDGAARD, H
    [J]. PHARMACEUTICAL RESEARCH, 1993, 10 (01) : 68 - 74